Tuberculosis Preventive Therapy in the Era of Primary Drug Resistance: A Primum Non Nocere Reappraisal
Journal of Public Health and Primary Care·
- DOI
- 10.4103/jphpc.jphpc_11_26
- PMID
- —
- PMCID
- —
- OpenAlex
- W7203636091
- Study type
- Journal article
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The paper raises ethical and policy concerns about tuberculosis preventive therapy in regions with high drug resistance, potentially informing TPT guidelines and harm-benefit assessments for latent TB treatment.
Structured evidence summary
Research question
The paper examines whether tuberculosis preventive therapy (TPT) in settings with high primary drug resistance may cause net harm to certain patients, challenging the assumption that anti-TB drugs function purely as bactericidal agents.
Study design
This is a conceptual or opinion article presenting a theoretical reappraisal of TPT policy and ethics rather than an empirical study with a defined methodology.
Population and setting
The discussion addresses patients receiving tuberculosis preventive therapy in high-resistance settings, though no specific population or geographic location is described in the abstract.
Main findings
The author argues that current TPT deployment in high-resistance settings may cause measurable net harm in a biologically definable and clinically significant subset of patients, and that this possibility has not received adequate scientific or ethical consideration.
Public-health relevance
The paper raises ethical and policy concerns about tuberculosis preventive therapy in regions with high drug resistance, potentially informing TPT guidelines and harm-benefit assessments for latent TB treatment.
Important limitations
This summary relies solely on the supplied single-article abstract and bibliographic metadata. The full paper is required for decision-grade interpretation of the theoretical arguments, supporting evidence, and the scope of populations potentially affected.
GIDS interpretation
This article was classified under Tuberculosis and Treatment topics. It addresses preventive therapy policy in drug-resistance contexts but does not report surveillance data or outbreak findings.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 5 auditable classifier relationships to diseases, places, topics, and study design.